S&P 500   5,088.80
DOW   39,131.53
QQQ   437.51
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
3 Chinese stocks poised for rebound
S&P 500   5,088.80
DOW   39,131.53
QQQ   437.51
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
3 Chinese stocks poised for rebound
S&P 500   5,088.80
DOW   39,131.53
QQQ   437.51
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
3 Chinese stocks poised for rebound
S&P 500   5,088.80
DOW   39,131.53
QQQ   437.51
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
3 Chinese stocks poised for rebound

Sangoma Technologies (SANG) Competitors

$3.83
-0.05 (-1.29%)
(As of 02/23/2024 06:55 PM ET)

SANG vs. GAN, PODC, HRYU, VNET, SIFY, TRUE, FLUX, ZENV, BCOV, and CBAT

Should you be buying Sangoma Technologies stock or one of its competitors? The main competitors of Sangoma Technologies include GAN (GAN), PodcastOne (PODC), Hanryu (HRYU), VNET Group (VNET), Sify Technologies (SIFY), TrueCar (TRUE), Flux Power (FLUX), Zenvia (ZENV), Brightcove (BCOV), and CBAK Energy Technology (CBAT). These companies are all part of the "computer and technology" sector.

Sangoma Technologies vs.

GAN (NASDAQ:GAN) and Sangoma Technologies (NASDAQ:SANG) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, community ranking, earnings, profitability and analyst recommendations.

GAN presently has a consensus target price of $2.50, suggesting a potential upside of 65.56%. Sangoma Technologies has a consensus target price of $4.83, suggesting a potential upside of 26.20%. Given Sangoma Technologies' higher probable upside, equities research analysts plainly believe GAN is more favorable than Sangoma Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GAN
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Sangoma Technologies
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40

GAN has a beta of 2.05, indicating that its stock price is 105% more volatile than the S&P 500. Comparatively, Sangoma Technologies has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500.

Sangoma Technologies has higher revenue and earnings than GAN. Sangoma Technologies is trading at a lower price-to-earnings ratio than GAN, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GAN$141.53M0.48-$197.50M-$4.03-0.37
Sangoma Technologies$252.53M0.36-$29.03M-$0.91-4.21

GAN received 6 more outperform votes than Sangoma Technologies when rated by MarketBeat users. Likewise, 33.33% of users gave GAN an outperform vote while only 23.81% of users gave Sangoma Technologies an outperform vote.

CompanyUnderperformOutperform
GANOutperform Votes
11
33.33%
Underperform Votes
22
66.67%
Sangoma TechnologiesOutperform Votes
5
23.81%
Underperform Votes
16
76.19%

Sangoma Technologies has a net margin of -11.92% compared to Sangoma Technologies' net margin of -127.37%. GAN's return on equity of -2.77% beat Sangoma Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
GAN-127.37% -188.72% -28.22%
Sangoma Technologies -11.92%-2.77%-1.70%

In the previous week, GAN had 1 more articles in the media than Sangoma Technologies. MarketBeat recorded 3 mentions for GAN and 2 mentions for Sangoma Technologies. GAN's average media sentiment score of 0.04 beat Sangoma Technologies' score of -0.06 indicating that Sangoma Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GAN
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sangoma Technologies
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

13.4% of GAN shares are owned by institutional investors. Comparatively, 59.0% of Sangoma Technologies shares are owned by institutional investors. 8.5% of GAN shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Sangoma Technologies beats GAN on 10 of the 18 factors compared between the two stocks.


Get Sangoma Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SANG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SANG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SANG vs. The Competition

MetricSangoma TechnologiesComputer & Data IndustryComputer SectorNASDAQ Exchange
Market Cap$91.54M$66.48B$18.58B$7.47B
Dividend YieldN/A0.63%2.73%3.86%
P/E Ratio-4.2140.00203.1113.11
Price / Sales0.3624.88529.9861.63
Price / Cash2.8531.9629.8825.71
Price / Book0.3410.067.064.76
Net Income-$29.03M$2.43B$614.70M$208.97M
7 Day Performance-1.54%-3.31%0.55%0.88%
1 Month Performance32.99%7.13%4.47%7.94%
1 Year Performance5.22%1.23%17.30%6.68%

Sangoma Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GAN
GAN
0.7902 of 5 stars
$1.55
-2.5%
$2.50
+61.3%
-23.2%$69.29M$141.53M-0.38701Gap Down
PODC
PodcastOne
0 of 5 stars
$1.85
-2.6%
N/AN/A$42.83MN/A0.00N/APositive News
Gap Down
HRYU
Hanryu
0 of 5 stars
$0.46
flat
N/AN/A$24.45M$900,000.000.0074Gap Up
VNET
VNET Group
2.7685 of 5 stars
$1.50
-4.5%
$3.00
+100.0%
-63.2%$233.07M$7.40B-5.003,293Gap Down
SIFY
Sify Technologies
0 of 5 stars
$1.28
-9.9%
N/A-16.8%$234.04M$416.18M0.004,439Gap Down
TRUE
TrueCar
1.2582 of 5 stars
$3.67
-2.1%
$3.75
+2.3%
+30.2%$332.71M$161.52M-4.89441
FLUX
Flux Power
2.4204 of 5 stars
$5.60
+5.7%
$9.00
+60.7%
-17.2%$92.57M$66.34M-15.56133Gap Up
ZENV
Zenvia
0 of 5 stars
$2.20
+15.2%
N/A+63.2%$91.83M$146.56M-2.471,191Positive News
Gap Up
BCOV
Brightcove
3.7687 of 5 stars
$2.18
-1.4%
$7.00
+221.1%
-64.6%$94.77M$211.01M-3.57671Analyst Report
Gap Down
CBAT
CBAK Energy Technology
0 of 5 stars
$1.06
flat
N/A-2.7%$94.86M$248.73M-10.601,063Positive News

Related Companies and Tools

This page (NASDAQ:SANG) was last updated on 2/26/2024 by MarketBeat.com Staff